Mol Pharm
From Bioblast
Revision as of 10:15, 20 July 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Journal |Title=[https://pubs.acs.org/journal/mpohbp Molecular Pharmaceutics] }}")
| Journal title and website | Molecular Pharmaceutics |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Pacheco-Velazquez 2018 Mol Pharm | Pacheco-Velázquez SC, Robledo-Cadena DX, Hernández-Reséndiz I, Gallardo-Pérez JC, Moreno-Sánchez R, Rodríguez-Enríquez S (2018) Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype. Mol Pharm 15:2151-64. | 2018 | PMID: 29746779 |
| Paredes-Gamero 2012 Mol Pharm | Paredes-Gamero EJ, Casaes-Rodrigues RL, Moura GE, Domingues TM, Buri MV, Ferreira VH, Trindade ES, Moreno-Ortega AJ, Cano-Abad MF, Nader HB, Ferreira AT, Miranda A, Justo GZ, Tersariol IL (2012) Cell-permeable gomesin peptide promotes cell death by intracellular Ca2+ overload. Mol Pharm 9:2686-97. | 2012 | PMID: 22873645 |
